share_log

Theriva Biologics | DEFR14A: Definitive proxy statement in connection with contested solicitations

SEC announcement ·  Aug 16, 2023 17:24
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more